| Biological Sciences | Lifetime | 517 | SE 8 | 99.94 |
| Immunology | Lifetime | 94 | SE 1 | 99.83 |
| Clinical Biochemistry | Lifetime | 22 | SE 1 | 99.52 |
| Radiology, Nuclear Medicine and Imaging | Lifetime | 611 | SE 7 | 98.41 |
| Oncology | Lifetime | 978 | SE 15 | 97.77 |
| Neuroscience of Neurology | Lifetime | 482 | SE 19 | 96.10 |
| Infectious Diseases | Lifetime | 866 | SE 10 | 95.83 |
| Virology | Lifetime | 336 | SE 2 | 91.88 |
| Neuroscience of Neurology | 2021-2025 | 265 | SE 5 | 83.37 |
| Immune Response and Inflammation | Lifetime | 40 | SE 1 | 99.86 |
| Advanced Glycation End Products research | Lifetime | 10 | SE 1 | 99.74 |
| Immune Cell Function and Interaction | Lifetime | 110 | SE 1 | 99.85 |
| Monoclonal and Polyclonal Antibodies Research | Lifetime | 173 | SE 5 | 99.63 |
| T-cell and B-cell Immunology | Lifetime | 121 | SE 1 | 99.74 |
| Immunodeficiency and Autoimmune Disorders | Lifetime | 114 | SE 3 | 99.32 |
| Vagus Nerve Stimulation Research | Lifetime | 12 | SE 1 | 99.07 |
| Immunotherapy and Immune Responses | Lifetime | 368 | SE 5 | 99.36 |
| Inflammasome and immune disorders | Lifetime | 123 | SE 2 | 98.49 |
| Neutrophil, Myeloperoxidase and Oxidative Mechanisms | Lifetime | 131 | SE 3 | 98.54 |
| Viral-associated cancers and disorders | Lifetime | 262 | SE 4 | 98.43 |
| HIV Research and Treatment | Lifetime | 711 | SE 7 | 98.29 |
| Glycosylation and Glycoproteins Research | Lifetime | 967 | SE 34 | 97.56 |
| Streptococcal Infections and Treatments | Lifetime | 440 | SE 15 | 97.57 |
| Cytomegalovirus and herpesvirus research | Lifetime | 860 | SE 12 | 96.86 |
| Parvovirus B19 Infection Studies | Lifetime | 286 | SE 7 | 96.86 |
| Diabetes and associated disorders | Lifetime | 983 | SE 40 | 96.75 |
| Pneumocystis jirovecii pneumonia detection and treatment | Lifetime | 999 | SE 9 | 95.60 |
| Autoimmune and Inflammatory Disorders Research | Lifetime | 858 | SE 18 | 95.01 |
| Kawasaki Disease and Coronary Complications | Lifetime | 358 | SE 2 | 93.18 |
| Cholesterol and Lipid Metabolism | Lifetime | 915 | SE 20 | 93.11 |
| Macrophage Migration Inhibitory Factor | Lifetime | 389 | SE 10 | 89.57 |
| Inflammation biomarkers and pathways | Lifetime | 703 | SE 7 | 73.56 |
| Vagus Nerve Stimulation Research | 2021-2025 | 51 | SE 2 | 92.24 |
| Advanced Glycation End Products research | 2021-2025 | 87 | SE 1 | 89.97 |
| Pharmacological Receptor Mechanisms and Effects | 2021-2025 | 368 | SE 3 | 63.47 |
